GlycoBien®

Home Glycobien

GlycoBien®

INDICATION: Diabetes

GlycoBien® CR is a novel once-daily oral hypoglycemic drug for lowering blood sugar and reduction of glucose spikes.

Discover GlycoBien®

Overview

GlycoBien® is designed to provide first-line therapy for both prediabetics and newly diagnosed Type 2 diabetic patients.

Phase

GlycoBien® CR is currently in Phase II clinical trial.

US Market ($B USD)

The estimated market for GlycoBien® in the United States is $8 Billion USD.

Global Market ($B USD)

The estimated market for GlycoBien® globally is $10 Billion USD.

Inquire About GlycoBien®